|
1
|
Akitomo T, Ogawa M, Kaneki A, Nishimura T, Usuda M, Kametani M, Kusaka S, Asao Y, Iwamoto Y, Tachikake M, Mitsuhata C, Nomura R. Dental Abnormalities in Pediatric Patients Receiving Chemotherapy. J Clin Med 2024; 13:2877. [PMID: 38792419 PMCID: PMC11122590 DOI: 10.3390/jcm13102877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 05/08/2024] [Accepted: 05/10/2024] [Indexed: 05/26/2024] Open
Abstract
Background: Chemotherapy is a common treatment for pediatric cancer. Although life prognosis is improving because of advances in medical science, it is important to deal with late effects such as dental abnormalities. We investigated the association between dental abnormalities and chemotherapy by age and tooth type. Methods: Among the 568 patients referred to the pediatric dentistry department of our hospital, we selected 32 patients (21 male and 11 female) who received chemotherapy between the ages of 0 and 6 and underwent panoramic examination after the age of 7. We recorded the age of chemotherapy commencement, diagnosis of systemic disease, and dental abnormalities such as congenital absence, microdonts, and short-rooted teeth. Results: Almost half of the patients had dental abnormalities such as congenital absence, microdonts, and short-rooted teeth, but there were no significant differences in the incidence of these abnormalities by age. When we analyzed the incidence of abnormal teeth by tooth type, the incidence of congenital absence was significantly higher in premolars (5.5%) and second molars (3.9%) than in incisor or canine or 1st molar (0.4%) (p < 0.01). The incidence of microdonts was significantly higher in premolars (3.9%) than in incisor or canine or 1st molar (0.2%) and second molars (0.0%) (p < 0.05). Conclusions: Patients who received chemotherapy had a high prevalence of dental abnormalities, and the incidence of abnormalities varied by tooth type. It is important to maintain long-term oral care for patients who have undergone chemotherapy even after the treatment is completed.
Collapse
Affiliation(s)
- Tatsuya Akitomo
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Masashi Ogawa
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Ami Kaneki
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Taku Nishimura
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Momoko Usuda
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Mariko Kametani
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Satoru Kusaka
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Yuria Asao
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Yuko Iwamoto
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Meiko Tachikake
- Department of Pediatric Dentistry, Hiroshima University Hospital, Hiroshima 734-8551, Japan;
| | - Chieko Mitsuhata
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| | - Ryota Nomura
- Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan; (M.O.); (A.K.); (T.N.); (M.U.); (M.K.); (S.K.); (Y.A.); (Y.I.); (C.M.); (R.N.)
| |
Collapse
|
|
2
|
Presentation of a Case of Short Root Anomaly in an 11-Year-Old Child. Case Rep Dent 2023; 2023:1766133. [PMID: 36643592 PMCID: PMC9833915 DOI: 10.1155/2023/1766133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 12/15/2022] [Accepted: 12/16/2022] [Indexed: 01/06/2023] Open
Abstract
Short root anomaly (SRA) is a developmental anomaly in which the affected teeth present morphologically normal crowns and short, round roots. The exact cause of SRA is unknown. A case of an 11-year-old female patient with SRA is described. The patient presented short, round roots of all permanent teeth but first molars. Maxillary lateral incisors presented severe root resorption and mobility. Treatment plan included preservation of the maxillary lateral incisors by splinting them to their adjacent teeth using a stainless steel coaxial wire. A custom mouthguard for dental trauma protection was also constructed using a computer-aided design - computer-aided manufacturing (CAD-CAM) system in order to fabricate 3D-printed dental casts. At 2-year follow-up, the mobility of maxillary lateral incisors decreased, and the patient's dentition remained stable. Considerations regarding differential diagnosis, orthodontic management, and treatment options after an eventual loss of teeth are thoroughly discussed.
Collapse
|
|
3
|
Mitus-Kenig M, Derwich M, Czochrowska E, Pawlowska E. Cancer survivors present significantly lower long-term stability of orthodontic treatment: a prospective case-control study. Eur J Orthod 2021; 43:631-638. [PMID: 33432985 PMCID: PMC8643400 DOI: 10.1093/ejo/cjaa083] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Background/Objectives The aim of the study was to compare the stability of orthodontic treatment in cancer survivors who had been treated with cytotoxic drugs with a generally healthy control group. Materials/Methods The study included 52 cancer survivors treated orthodontically and 52 healthy control subjects matched for age, gender, and malocclusion. The weighted Peer Assessment Rating (w-PAR) index, the Index of Complexity, Outcome and Need (ICON) were assessed before treatment, after the treatment, and at the 3-year follow-up. Patients Satisfaction Score was assessed after the treatment and at the 3-year follow-up. A repeated analysis of variance test was used to check the statistical significance between the scores. Results Ideal occlusion was achieved in all patients. The mean w-PAR and ICON values were significantly reduced in both groups after the end of the orthodontic treatment with no significant differences between the groups regarding the obtained results. However, after the 3-year follow-up, only the cancer survivors’ group presented statistically significant (P < 0.001) increase of the w-PAR and ICON values comparing to the values obtained at the end of the treatment. There was no significant change in Patients’ Satisfaction Score within 3 years after treatment. Limitations The limited size of the study sample as well as different types of oncological diagnoses could have had an impact on the final results of the study. Conclusions/Implications Previous cytotoxic drug treatment significantly decreases the stability of orthodontic treatment among the cancer survivors, particularly within first 12 months after the end of the treatment.
Collapse
Affiliation(s)
- Maria Mitus-Kenig
- Department of Experimental Dentistry and Prophylaxis, Medical College, Jagiellonian University in Krakow
| | - Marcin Derwich
- ORTODENT, Specialist Orthodontic Private Practice in Grudziadz
| | | | | |
Collapse
|